DK418587D0 - PROCEDURE FOR ANALYSIS OF IMMUNOGENIC PEPTID SEQUENCES - Google Patents

PROCEDURE FOR ANALYSIS OF IMMUNOGENIC PEPTID SEQUENCES

Info

Publication number
DK418587D0
DK418587D0 DK418587A DK418587A DK418587D0 DK 418587 D0 DK418587 D0 DK 418587D0 DK 418587 A DK418587 A DK 418587A DK 418587 A DK418587 A DK 418587A DK 418587 D0 DK418587 D0 DK 418587D0
Authority
DK
Denmark
Prior art keywords
sequences
immunogenic
analysis
procedure
host
Prior art date
Application number
DK418587A
Other languages
Danish (da)
Other versions
DK418587A (en
Inventor
Philippe Kourilsky
Jean-Michel Claverie
Original Assignee
Pasteur Institut
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Inst Nat Sante Rech Med filed Critical Pasteur Institut
Publication of DK418587D0 publication Critical patent/DK418587D0/en
Publication of DK418587A publication Critical patent/DK418587A/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Method for analyzing peptide sequences carrying an epitope characteristic of an antigenic protein to the organism of a host. Said method comprises the detection of those tetrapeptidic sequences contained in the antigenic protein which have no counterpart in a data bank gathering information relative to the amino acid sequences of the proteins of the ''somatic self'' of the host. The synthesis of the peptidic sequences is carried out and their capacity to induce in vivo antibodies active against all of the protein is tested.
DK418587A 1986-06-19 1987-08-11 PROCEDURE FOR ANALYSIS OF IMMUNOGENIC PEPTID SEQUENCES DK418587A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8608896A FR2600335B1 (en) 1986-06-19 1986-06-19 METHOD OF ANALYZING IMMUNOGENIC PEPTIDE SEQUENCES CARRYING A CHARACTERISTIC EPITOPE OF A FOREIGN PROTEIN WITH THE ORGANISM OF A LIVING HOST, FOR VACCINE PRODUCTION
PCT/FR1987/000236 WO1987007958A1 (en) 1986-06-19 1987-06-19 Method for analyzing immunogenic peptide sequences with a view to the production of vaccines

Publications (2)

Publication Number Publication Date
DK418587D0 true DK418587D0 (en) 1987-08-11
DK418587A DK418587A (en) 1987-12-30

Family

ID=9336503

Family Applications (1)

Application Number Title Priority Date Filing Date
DK418587A DK418587A (en) 1986-06-19 1987-08-11 PROCEDURE FOR ANALYSIS OF IMMUNOGENIC PEPTID SEQUENCES

Country Status (8)

Country Link
EP (1) EP0253698B1 (en)
JP (1) JPS63503568A (en)
AT (1) ATE76513T1 (en)
DE (1) DE3779200D1 (en)
DK (1) DK418587A (en)
FR (1) FR2600335B1 (en)
PT (1) PT85130B (en)
WO (1) WO1987007958A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2632310B1 (en) * 1988-06-06 1992-04-10 Pasteur Institut PEPTIDES HAVING PROTECTIVE PROPERTIES OF A PATHOGENIC VIRUS OF THE HIV TYPE IN SENSITIVE CELLS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984003506A1 (en) * 1983-03-08 1984-09-13 Commw Serum Lab Commission Antigenically active amino acid sequences

Also Published As

Publication number Publication date
WO1987007958A1 (en) 1987-12-30
JPS63503568A (en) 1988-12-22
EP0253698B1 (en) 1992-05-20
DE3779200D1 (en) 1992-06-25
FR2600335A1 (en) 1987-12-24
ATE76513T1 (en) 1992-06-15
PT85130A (en) 1987-07-01
DK418587A (en) 1987-12-30
PT85130B (en) 1990-03-30
EP0253698A1 (en) 1988-01-20
FR2600335B1 (en) 1988-09-30

Similar Documents

Publication Publication Date Title
ATE319091T1 (en) DIAGNOSIS OF NATIVE SPRUE/CELIAC DISEASE USING GLIADINE PITOPES
Hoffman Allergens in bee venom: III. Identification of allergen B of bee venom as an acid phosphatase
ATE442439T1 (en) MELANOMA ANTIGENE P15 AND THEIR APPLICATION IN DIAGNOSTIC AND THERAPEUTIC PROCEDURES
ES2133269T3 (en) RECEPTOR GENE OF THE GROWTH FACTOR DERIVED FROM OC-TYPE PLATELETS.
Aronstein et al. Identification of species-specific and gender-specific proteins and glycoproteins of three human schistosomes
Cabral et al. Ultrastructural localization to 10 nm filaments of an insoluble 58K protein in cultured fibroblasts.
ATE431414T1 (en) TRANSPORT PEPTIDES DERIVED FROM ERNS PROTEIN
BR9714133A (en) isolated nucleic acid, molecule thereof, probe, recombinant expression vector, cell, polypeptide, fusion protein vaccine formulation and processes for producing a h. pylori, to detect the presence of a helicobacter nucleic acid in a sample, to treat or reduce a risk of infection by h. pylori in an individual and to produce a vaccine formulation
DK418587D0 (en) PROCEDURE FOR ANALYSIS OF IMMUNOGENIC PEPTID SEQUENCES
Mandel Electrophoretic studies of saliva
NO175639C (en) Peptide, antibody obtained by the peptide, a method for immunologically determining intact procollagen peptide (type III) and use of the peptide
KR100237250B1 (en) Antigenic regions of tumour-liberated particles(tlp) complexes and antibodies against them
DE69733957D1 (en) PROCEDURE FOR DETECTING THE PRESENCE OF BRAIN SPECIFIC PROTEIN S-100 BETA
ATE297470T1 (en) EXPRESSION CASSETTE OF A PROTEIN P30 FROM TOXOPLASMA GONDII
GB9401689D0 (en) Diagnosis and treatment of endocarditis
NO178504C (en) Method for Preparation of Minactivin, DNA Molecule, Gene, Host, Probes, Preparations Including Probes, Reagents for Localization and Definition. of limits for tumor in histological specimens, as well as the use of DNA molecule, minactivin and preparation
DK312088D0 (en) HIS UNKNOWN PEPTIDES AND APPLICATIONS THEREOF
ATE141645T1 (en) IN VITRO TREATMENT OF FUSION PROTEINS
Stockell Comparative studies on tryptic digests of myoglobins
DE3877136D1 (en) RECOMBINANT HISTIDINE PROTEIN OF PLASMODIUM FALCIPARUM, ITS PRODUCTION AND USE.
WO1997015324B1 (en) High fluorescence specific immune enhancing factor and methods of use for same
Kehoe Evolutionary Divergence of Immunoglobulin Constant Region Genes

Legal Events

Date Code Title Description
A0 Application filed
AHB Application shelved due to non-payment